0.10Open0.10Pre Close0 Volume3 Open Interest9.00Strike Price0.00Turnover360.00%IV90.38%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.1151Delta0.0914Gamma47.80Leverage Ratio-0.0352Theta0.0001Rho5.50Eff Leverage0.0011Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet